2 Firms Lead Precision BioSciences' $126M IPO
By Abraham Gross ( March 28, 2019, 5:34 PM EDT) -- Cancer-focused biotech Precision BioSciences Inc. began trading Thursday after pricing units Wednesday night in a $126.4 million initial public offering led by Smith Anderson Blount Dorsett Mitchell & Jernigan LLP and Latham & Watkins LLP....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.